UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024079
Receipt number R000027720
Scientific Title The study of left-sided portal hypertention after pancreaticoduodenectomy with combined resection of portal vein for pancreatic cancer
Date of disclosure of the study information 2016/10/01
Last modified on 2021/03/21 23:11:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of left-sided portal hypertention after pancreaticoduodenectomy with combined resection of portal vein for pancreatic cancer

Acronym

The study of left-sided portal hypertention after pancreaticoduodenectomy with combined resection of portal vein

Scientific Title

The study of left-sided portal hypertention after pancreaticoduodenectomy with combined resection of portal vein for pancreatic cancer

Scientific Title:Acronym

The study of left-sided portal hypertention after pancreaticoduodenectomy with combined resection of portal vein

Region

Japan


Condition

Condition

pancreatic head cancer

Classification by specialty

Hepato-biliary-pancreatic surgery Operative medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify the incidence and impact of left-sided portal hypertention after PD for pancreatic cancer, which have yet to be elucidated.

Basic objectives2

Others

Basic objectives -Others

Even in the high volume centers, the method to prevent the left-sided portal hypertention is still not standardized. Therefore, we evaluate the best procedure for its prevention using multi-center questionaries.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The incidence of left-sided portal hypertention according to the various procedures.
To identify it, we evaluate the incidence of gastrointestinal bleedings from the varices, platelets counts and spleen volume on POD 6 and 12 months

Key secondary outcomes

Analysis if various risk factors causing the left-sided portal hypertention after pancreaticduodenectomy


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Cases in which PD with PV resection were conducted.
2) Patients whose CT scan and Lab data were available on POM 6 and 12.

Key exclusion criteria

The patients of whom the criteria above mentioned were not satisfied.

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name Shugo
Middle name
Last name Mizuno

Organization

Mie university

Division name

Hepatobiliary pancreatic and transplant surgery

Zip code

514-8507

Address

2-174 Edobashi Tsu Mie, Japan ZIP:514-8507

TEL

0592321111

Email

isaji-s@clin.medic.mie-u.ac.jp


Public contact

Name of contact person

1st name Shugo
Middle name
Last name Mizuno

Organization

Mie university

Division name

Hepatobiliary pancreatic and transplant surgery

Zip code

514-8507

Address

2-174 Edobashi Tsu Mie, Japan ZIP:514-8507

TEL

0592321111

Homepage URL


Email

mizunos@clin.medic.mie-u.ac.jp


Sponsor or person

Institute

Hepatobiliary pancreatic and transplant surgery, Mie university

Institute

Department

Personal name



Funding Source

Organization

Japanese society of hepatobiliary pancreatic surgery

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mie University Graduate School of Medicine

Address

2-174Tsu Edobashi

Tel

0592321111

Email

katohiroyuki510719@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 18 Day

Date of IRB

2016 Year 04 Month 18 Day

Anticipated trial start date

2016 Year 09 Month 10 Day

Last follow-up date

2019 Year 07 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We distributed the the first questionaries to the A ranked hospitals authorized by the Japanese society of hepatobiliary pancreatic surgery and selected the institutions in which PD with PV resection were carried out at least 10 cases from 2005.1 to 2014.12.


Management information

Registered date

2016 Year 09 Month 16 Day

Last modified on

2021 Year 03 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027720


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name